Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: PINE PHARMACEUTICALS LLC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-06-30 to 2024-06-29
Current total value of award: $230422.8
Description: THE PURPOSE OF THIS ACQUISITION IS TO PROCURE A PINE PHARMACEUTICAL INTRAVENOUS STABLE ISOTOPE.